STRATA Skin Sciences, Inc. (SSKN)
USD 2.59
(-1.19%)
USD 2.59
(-1.19%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 42.01 Million USD | -19.62% |
| 2022 | 52.27 Million USD | 12.19% |
| 2021 | 46.59 Million USD | -0.4% |
| 2020 | 46.77 Million USD | -1.19% |
| 2019 | 47.34 Million USD | -0.35% |
| 2018 | 47.5 Million USD | 22.98% |
| 2017 | 38.63 Million USD | -10.56% |
| 2016 | 43.19 Million USD | -15.92% |
| 2015 | 51.37 Million USD | 155.96% |
| 2014 | 20.07 Million USD | 42.02% |
| 2013 | 14.13 Million USD | -18.17% |
| 2012 | 17.26 Million USD | -44.99% |
| 2011 | 31.39 Million USD | -6.54% |
| 2010 | 33.58 Million USD | 4.55% |
| 2009 | 32.12 Million USD | 93.31% |
| 2008 | 16.61 Million USD | -24.83% |
| 2007 | 22.1 Million USD | -1.64% |
| 2006 | 22.47 Million USD | 17.27% |
| 2005 | 19.16 Million USD | 170.09% |
| 2004 | 7.09 Million USD | 1542.63% |
| 2003 | 432 Thousand USD | 25.58% |
| 2002 | 344 Thousand USD | -69.58% |
| 2001 | 1.13 Million USD | -70.35% |
| 2000 | 3.81 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 39.58 Million USD | -1.17% |
| 2024 Q1 | 40.04 Million USD | -4.68% |
| 2023 FY | 42.01 Million USD | -19.62% |
| 2023 Q1 | 49.12 Million USD | -6.02% |
| 2023 Q3 | 47.19 Million USD | -14.51% |
| 2023 Q2 | 55.2 Million USD | 12.38% |
| 2023 Q4 | 42.01 Million USD | -10.97% |
| 2022 Q4 | 52.27 Million USD | -1.81% |
| 2022 Q3 | 53.23 Million USD | -0.66% |
| 2022 FY | 52.27 Million USD | 12.19% |
| 2022 Q1 | 55.08 Million USD | 18.23% |
| 2022 Q2 | 53.58 Million USD | -2.72% |
| 2021 Q4 | 46.59 Million USD | -0.35% |
| 2021 Q1 | 45.85 Million USD | -1.98% |
| 2021 Q2 | 44.89 Million USD | -2.08% |
| 2021 Q3 | 46.75 Million USD | 4.14% |
| 2021 FY | 46.59 Million USD | -0.4% |
| 2020 Q4 | 46.77 Million USD | -0.61% |
| 2020 Q3 | 47.06 Million USD | 1.85% |
| 2020 Q2 | 46.21 Million USD | 0.35% |
| 2020 Q1 | 46.04 Million USD | -2.74% |
| 2020 FY | 46.77 Million USD | -1.19% |
| 2019 Q1 | 47.73 Million USD | 0.49% |
| 2019 Q3 | 47.51 Million USD | -0.94% |
| 2019 Q4 | 47.34 Million USD | -0.37% |
| 2019 FY | 47.34 Million USD | -0.35% |
| 2019 Q2 | 47.96 Million USD | 0.48% |
| 2018 Q2 | 45.65 Million USD | 24.21% |
| 2018 Q1 | 36.75 Million USD | -4.86% |
| 2018 Q4 | 47.5 Million USD | 2.85% |
| 2018 FY | 47.5 Million USD | 22.98% |
| 2018 Q3 | 46.19 Million USD | 1.18% |
| 2017 FY | 38.63 Million USD | -10.56% |
| 2017 Q1 | 43.2 Million USD | 0.03% |
| 2017 Q2 | 42.9 Million USD | -0.71% |
| 2017 Q3 | 39.86 Million USD | -7.08% |
| 2017 Q4 | 38.63 Million USD | -3.09% |
| 2016 FY | 43.19 Million USD | -15.92% |
| 2016 Q4 | 43.19 Million USD | 0.57% |
| 2016 Q3 | 42.95 Million USD | -3.28% |
| 2016 Q2 | 44.4 Million USD | -6.53% |
| 2016 Q1 | 47.5 Million USD | -7.52% |
| 2015 Q4 | 51.37 Million USD | -1.5% |
| 2015 Q3 | 52.15 Million USD | -4.15% |
| 2015 Q2 | 54.41 Million USD | 235.43% |
| 2015 Q1 | 16.22 Million USD | -19.17% |
| 2015 FY | 51.37 Million USD | 155.96% |
| 2014 Q2 | 12.49 Million USD | -28.02% |
| 2014 Q4 | 20.07 Million USD | -17.45% |
| 2014 Q3 | 24.31 Million USD | 94.65% |
| 2014 FY | 20.07 Million USD | 42.02% |
| 2014 Q1 | 17.35 Million USD | 22.8% |
| 2013 Q2 | 26.59 Million USD | -16.45% |
| 2013 FY | 14.13 Million USD | -18.17% |
| 2013 Q4 | 14.13 Million USD | 7.47% |
| 2013 Q3 | 13.14 Million USD | -50.57% |
| 2013 Q1 | 31.83 Million USD | 84.34% |
| 2012 Q4 | 17.26 Million USD | -14.25% |
| 2012 Q2 | 21.9 Million USD | -16.17% |
| 2012 FY | 17.26 Million USD | -44.99% |
| 2012 Q3 | 20.14 Million USD | -8.04% |
| 2012 Q1 | 26.12 Million USD | -16.78% |
| 2011 Q2 | 24.16 Million USD | -16.12% |
| 2011 Q4 | 31.39 Million USD | 54.68% |
| 2011 Q3 | 20.29 Million USD | -16.02% |
| 2011 FY | 31.39 Million USD | -6.54% |
| 2011 Q1 | 28.81 Million USD | -14.22% |
| 2010 Q4 | 33.58 Million USD | -13.56% |
| 2010 FY | 33.58 Million USD | 4.55% |
| 2010 Q3 | 38.85 Million USD | 37.76% |
| 2010 Q2 | 28.2 Million USD | -13.25% |
| 2010 Q1 | 32.51 Million USD | 1.21% |
| 2009 Q3 | 26.12 Million USD | 191.5% |
| 2009 FY | 32.12 Million USD | 93.31% |
| 2009 Q4 | 32.12 Million USD | 22.96% |
| 2009 Q1 | 12.65 Million USD | -23.86% |
| 2009 Q2 | 8.96 Million USD | -29.17% |
| 2008 Q3 | 20.57 Million USD | 49.91% |
| 2008 Q2 | 13.72 Million USD | -25.18% |
| 2008 Q1 | 18.34 Million USD | -17.04% |
| 2008 FY | 16.61 Million USD | -24.83% |
| 2008 Q4 | 16.61 Million USD | -19.21% |
| 2007 Q4 | 22.1 Million USD | -10.75% |
| 2007 Q2 | 16.62 Million USD | -15.71% |
| 2007 Q1 | 19.72 Million USD | -12.22% |
| 2007 Q3 | 24.77 Million USD | 48.98% |
| 2007 FY | 22.1 Million USD | -1.64% |
| 2006 FY | 22.47 Million USD | 17.27% |
| 2006 Q4 | 22.47 Million USD | 94.7% |
| 2006 Q3 | 11.54 Million USD | -17.3% |
| 2006 Q2 | 13.95 Million USD | -16.44% |
| 2006 Q1 | 16.7 Million USD | -12.84% |
| 2005 FY | 19.16 Million USD | 170.09% |
| 2005 Q3 | 3.64 Million USD | -27.11% |
| 2005 Q4 | 19.16 Million USD | 426.16% |
| 2005 Q2 | 4.99 Million USD | 0.0% |
| 2004 FY | 7.09 Million USD | 1542.63% |
| 2004 Q4 | 7.09 Million USD | 0.0% |
| 2003 FY | 432 Thousand USD | 25.58% |
| 2002 FY | 344 Thousand USD | -69.58% |
| 2001 FY | 1.13 Million USD | -70.35% |
| 2000 FY | 3.81 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -33.954% |
| BrainsWay Ltd. | 62.97 Million USD | 33.278% |
| Cerus Corporation | 197.74 Million USD | 78.753% |
| Envoy Medical, Inc. | 7.64 Million USD | -449.948% |
| electroCore, Inc. | 16.38 Million USD | -156.398% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -446.23% |
| IceCure Medical Ltd | 16.41 Million USD | -156.039% |
| Inogen, Inc. | 326.19 Million USD | 87.119% |
| OrthoPediatrics Corp. | 449.58 Million USD | 90.655% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -54.074% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -153.429% |
| MaxCyte, Inc. | 268.27 Million USD | 84.338% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -418.888% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1056.855% |
| Orthofix Medical Inc. | 925.31 Million USD | 95.459% |
| PAVmed Inc | 33.11 Million USD | -26.864% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 70.711% |
| RxSight, Inc. | 182.55 Million USD | 76.984% |
| Sight Sciences, Inc. | 166.65 Million USD | 74.788% |
| SI-BONE, Inc. | 230.42 Million USD | 81.766% |
| TELA Bio, Inc. | 78.04 Million USD | 46.166% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 83.321% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -291.575% |
| Acutus Medical, Inc. | 53.96 Million USD | 22.135% |
| Talis Biomedical Corporation | 98.34 Million USD | 57.275% |
| Spectral AI, Inc. | 10.69 Million USD | -292.967% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 80.784% |
| CVRx, Inc. | 115.22 Million USD | 63.537% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 28.375% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -1248.719% |
| Bioventus Inc. | 810.91 Million USD | 94.819% |
| Venus Concept Inc. | 93.65 Million USD | 55.137% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -63.328% |
| LivaNova PLC | 2.42 Billion USD | 98.271% |
| 908 Devices Inc. | 202.98 Million USD | 79.301% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 94.782% |
| Nemaura Medical Inc. | 14.56 Million USD | -188.507% |
| NeuroPace, Inc. | 107.65 Million USD | 60.97% |
| LENSAR, Inc. | 69.58 Million USD | 39.619% |
| Apyx Medical Corporation | 79.24 Million USD | 46.976% |
| Cutera, Inc. | 346.29 Million USD | 87.867% |
| BioSig Technologies, Inc. | 1.79 Million USD | -2236.819% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 84.475% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 1.512% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 98.889% |
| Axonics, Inc. | 719.92 Million USD | 94.164% |
| Outset Medical, Inc. | 313.8 Million USD | 86.611% |
| IRIDEX Corporation | 34.43 Million USD | -22.012% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 89.618% |
| IRadimed Corporation | 92.15 Million USD | 54.408% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -699.695% |
| INVO Bioscience, Inc. | 20.88 Million USD | -101.151% |
| Telesis Bio, Inc. | 70.41 Million USD | 40.328% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 72.735% |
| Varex Imaging Corporation | 1.24 Billion USD | 96.638% |
| Quipt Home Medical Corp. | 247.4 Million USD | 83.018% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -351.3% |
| Pulmonx Corporation | 178.95 Million USD | 76.521% |
| Dynatronics Corporation | 25.94 Million USD | -61.97% |
| Modular Medical, Inc. | 13.8 Million USD | -204.309% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -291.685% |
| Semler Scientific, Inc. | 78.06 Million USD | 46.178% |
| InMode Ltd. | 863.28 Million USD | 95.133% |
| Bruker Corporation | 4.24 Billion USD | 99.011% |
| Cytosorbents Corporation | 53.26 Million USD | 21.112% |
| DexCom, Inc. | 6.26 Billion USD | 99.329% |
| Align Technology, Inc. | 6.08 Billion USD | 99.309% |
| Viveve Medical, Inc. | 25.91 Million USD | -62.143% |
| ZimVie Inc. | 1.2 Billion USD | 96.514% |
| Movano Inc. | 9.42 Million USD | -345.982% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 91.557% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1056.855% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 28.375% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 95.59% |
| Profound Medical Corp. | 43.68 Million USD | 3.823% |
| Insulet Corporation | 2.58 Billion USD | 98.377% |
| enVVeno Medical Corporation | 48.63 Million USD | 13.61% |
| Surmodics, Inc. | 185.73 Million USD | 77.378% |
| iCAD, Inc. | 41.41 Million USD | -1.444% |
| Nuwellis, Inc. | 9.77 Million USD | -330.051% |
| Biotricity, Inc. | 5.94 Million USD | -607.028% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 90.3% |
| Aethlon Medical, Inc. | 8.24 Million USD | -409.533% |
| InspireMD, Inc. | 47.64 Million USD | 11.811% |
| PAVmed Inc. | 33.11 Million USD | -26.864% |
| BIOLASE, Inc. | 35.1 Million USD | -19.7% |
| Beyond Air, Inc. | 56.96 Million USD | 26.237% |
| FONAR Corporation | 214.24 Million USD | 80.389% |
| AxoGen, Inc. | 196.82 Million USD | 78.653% |
| Vivani Medical, Inc. | 45.79 Million USD | 8.256% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 85.071% |
| Inari Medical, Inc. | 674.23 Million USD | 93.768% |
| UFP Technologies, Inc. | 404.13 Million USD | 89.603% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -79.567% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -342.129% |
| Tenon Medical, Inc. | 6.34 Million USD | -562.191% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -346.646% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 59.463% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.091% |
| Sintx Technologies, Inc. | 15.36 Million USD | -173.453% |
| NanoVibronix, Inc. | 6.67 Million USD | -529.547% |
| Quanterix Corporation | 425.01 Million USD | 90.114% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -351.3% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 21.797% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 97.594% |
| TransMedics Group, Inc. | 706.04 Million USD | 94.049% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 33.511% |
| NeuroMetrix, Inc. | 21.42 Million USD | -96.112% |
| Hyperfine, Inc. | 94.19 Million USD | 55.397% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 84.36% |
| Biomerica, Inc. | 9.25 Million USD | -354.031% |
| Bone Biologics Corporation | 3.73 Million USD | -1024.095% |
| AVITA Medical, Inc. | 144.33 Million USD | 70.891% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -763.012% |
| Silk Road Medical, Inc | 265.3 Million USD | 84.163% |